References
- Klein HG, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 11th ed. Malden, MA: Blackwell Science, 2005: 185–6.
- Issitt PD, Anstee PD. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.
- Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.
- Daniels G. Human blood groups. 2nd ed. Malden, MA: Blackwell Science, 2002.
- Mollison PL, Hughes-Jones NC, Lindsay M, Wessely J. Suppression of primary Rh immunization by passively administered antibody. Experiments in volunteers. Vox Sang 1969;16:421–39.
- Woodrow JC, Clarke CA, Donohow WT, et al. Mechanism of Rh prophylaxis: an experimental study on specificity of immunosuppression. Br Med J 1975;2:57–9.
- Samson D, Mollison PL. Effect on primary Rh immunization of delayed administration of anti-Rh. Immunology 1975;28: 349–57.
- Contreras M, Mollison PL. Failure to augment primary RD immunization using a small dose of “passive” IgG anti-Rh. Br J Haematol 1981;49:371–81.
- Gunson HH, Stratton F, Cooper DG, Rawlinson VI. Primary immunization of Rh-negative volunteers. Br Med J 1970;1: 593–5.
- Pollack W, Ascari WQ, Crispen JF, O’Connor RR, Ho TY. Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh-positive blood. Transfusion 1971;11: 340–4.
- Urbaniak SJ, Robertson AE. A successful program of immunizing Rh-negative male volunteers for anti-D production using frozen/thawed blood. Transfusion 1981;21:64–9.
- Gonzalea-Porras JR, Graciani IF, Perez-Simon JA, et al. Prospective evaluation of a transfusion policy of D+ red blood cells into D– patients. Transfusion 2008;48:1318–24.
- Yazer MH, Triulzi DJ. Detection of anti-D in D– recipients transfused with D+ red blood cells. Transfusion 2007;47: 2197–201.
- Frohn C, Dümbgen L, Brand JM, Görg S, Luhm J, Kirchner H. Probability of anti-D development in D– patients receiving D+ RBCs. Transfusion 2003;43:893–8.
- Mijovic A. Alloimmunization to RhD antigen in RhD-incompatible haematopoietic cell transplants with nonmyeloablative conditioning. Vox Sang 2002;83:358–62.
- Cid J, Lozano M, Fernández-Avilés F, et al. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases. Transfusion 2006;46:169–73.
- Ramsey G, Hahn LF, Cornell FW, et al. Low rate of Rhesus immunization from Rh incompatible blood transfusions during liver and heart transplant surgery. Transplantation 1989;47:993–5.
- Casanueva M, Valdes MD, Ribera MC. Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion 1994;34:570–2.
- Yuan S, Davis R, Lu Q, Goldfinger D, Ziman AF. Low risk of alloimmunization to the D antigen in D– orthotopic liver transplant recipients receiving D+ RBCs perioperatively (letter). Transfusion 2008;48:2653–5.
- Boctor FN, Ali NM, Mohandas K, Uehlinger J. Absence of D– alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion 2003;43:173–6.
- Lichtiger B, Surgeon J, Rhorer S. Rh-incompatible platelet transfusion therapy in cancer patients: a study of 30 cases. Vox Sang 1983;45:139–43.
- Cid J, Ortin X, Elies E, Castella D, Panadés M, Martín-Vega C. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002; 42:173–6.
- Molnar R, Johnson R, Sweat LT, Geiger TL. Absence of D alloimmunization in D– pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 2002;42:177–82.
- Goldfinger D, McGinniss MH. Rh-incompatible platelet transfusions—risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971;284:942–4.
- Baldwin ML, Ness PM, Scott D, Braine H, Kickler TS. Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion 1988;28:330–3.
- Atoyebi W, Mundy N, Croxton T, Littlewood TJ, Murphy MF. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol 2000;111:980–3.
- Cid J, Carbassé G, Pereira A, et al. Platelet transfusions from D+ donors to D– patients: a 10-year follow-up study of 1014 patients. Transfusion 2011;51:1163–9.
- Asfour M, Narvios A, Lichtiger B. Transfusion of RhD-incompatible blood components in RhD-negative bone marrow transplant recipients. MedGenMed 2004;6:22–7.
- Renton PH, Hancock JA. Variability of the rhesus antigen D. Br J Haematol 1956;2:295–304.
- Pollack W, Ascari WQ, Kochesky RJ, O’Connor RR, Ho TY, Tripodi D. Studies on Rh prophylaxis. I. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333–9.
- Ting A, Pun A, Dodds AJ, Atkinson K, Biggs JC. Red cell alloantibodies produced after bone marrow transplantation. Transfusion 1987;27:145–7.
- Abou-Elella AA, Camarillo TA, Allen MB, et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995;35:931–5.
- Dunstan RA, Simpson MB, Rosse WF. Erythrocyte antigens on human platelets. Absence of the Rh, Duffy, Kell, Kidd and Lutheran antigens. Transfusion 1984:24:243–60.
- Menitove JE. Immunoprophylaxis for D– patients receiving platelet transfusions from D+ donors? (editorial). Transfusion 2002;42:136–8.
- Bolaños-Meade J, Fuch EJ, Luznik L, et al. HLA-haploidentical bone marrow transplantation with posttransfusion cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 2012;120:4285–91.